Medication Adherence Market
Medication Adherence Market Forecasts to 2030 - Global Analysis By Type (Software Centric, Hardware Centric and Other Types), Medication and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $4,403.1 MN |
|
Projected Year Value (2030) |
US $13,615.3 MN |
|
CAGR (2023 - 2030) |
17.5% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Medication Adherence Market is accounted for $4,403.1 million in 2023 and is expected to reach $13,615.3 million by 2030 growing at a CAGR of 17.5% during the forecast period. An important component of medical treatment accomplishment is medication adherence, or the extent to which patients adhere to their recommended prescription regimes. A variety of technologies, therapies, and services are available on the market with the aim of enhancing and tracking patient adherence to drug regimes. In order to improve communication between healthcare providers and patients and eventually ensure individuals follow their recommended medication routines, innovations in this sector include wearable technology, smart pill dispensers, mobile health apps, and patient education programs.
According to a CMS.gov December 2022 update, national health expenditure grew 2.7% to USD 4.3 trillion in 2021, or USD 12,914 per person, and accounted for 18.3% of the Gross Domestic Product (GDP) in the United States.
Market Dynamics:
Driver:
Regulatory initiatives
The substantial impact that medication non-adherence has on healthcare outcomes and expenditures is becoming increasingly recognized by governments and regulatory authorities in the healthcare industry globally. In response, a number of laws and guidelines have been put into effect to promote the use of medication adherence programs. Additionally, guidelines encouraging the use of technology-driven adherence tools, payment incentives for healthcare professionals using adherence techniques, and the incorporation of adherence measurements into quality reporting metrics are just a few instances of these initiatives. A supportive regulatory framework promotes the creation and application of cutting-edge adherence services and technologies.
Restraint:
Lack of standardization
The lack of standardized protocols and data formats impedes technology connectivity, making it challenging for healthcare organizations to implement an integrated approach. This lack of standardization restricts the scalability and effectiveness of adherence interventions, in addition to making the creation of comprehensive and interoperable solutions more difficult. However, it may be challenging for healthcare professionals to gather and assess data from various adherence technologies, which makes it more difficult to arrive at insightful inferences and deliver customized therapy.
Opportunity:
Rising chronic disease burden
As diseases like diabetes, heart problems, and respiratory disorders become more common, it is crucial that individuals keep using medications as prescribed in order to effectively manage illness. Because chronic therapies are complex and long-term, it is essential for patients to adhere to their recommended drug schedules in order to avoid issues and enhance their overall health. Moreover, innovation in products and services that support and track medication compliance is being fueled by the increased need for adherence solutions.
Threat:
Cost of adherence solutions
The upfront costs and continuous expenses associated with these solutions can be prohibitively expensive, even though cutting-edge technologies and digital platforms provide sophisticated ways to enhance prescription compliance. Healthcare payers, providers, and, in certain situations, patients are all affected by this cost issue. In contexts with limited resources, the implementation and maintenance of adherence technologies like digital monitoring systems and smart devices could put pressure on healthcare costs. Financial constraints may prevent these treatments from being widely adopted, which would affect their efficacy and accessibility for a range of patient populations.
Covid-19 Impact:
The pandemic's effects, including lockdowns and overloaded healthcare systems, emphasized how important it is for patients to take their prescriptions as prescribed. Medication adherence has become more important as a way to manage and prevent complications, as there is a greater understanding of the way the virus can have serious effects on those with chronic diseases. Additionally, the pandemic's rapid telehealth uptake has created opportunities for remote monitoring and adherence assistance.
The software centric segment is expected to be the largest during the forecast period
With a focus on software-based interventions such as web platforms, mobile applications, and electronic health record connections, the software-centric category is predicted to have the largest share. Patients have the ability to manage their treatment programs with the help of these software solutions, which frequently include features like dosage tracking, real-time monitoring, and drug reminders. Additionally, they also make it easier for patients and healthcare professionals to communicate, enabling customized adherence plans. With the integration of AI, ML, and data analytics to customize interventions to specific patient needs, the software-centric sector is experiencing exponential innovation.
The oncology segment is expected to have the highest CAGR during the forecast period
With an emphasis on enhancing drug adherence for patients undergoing cancer treatment, the oncology segment is predicted to experience profitable growth. Because oncology medicines are so complex and intense, maintaining precise compliance is essential to maximizing therapeutic outcomes. These solutions improve the patient's understanding and participation by offering individualized drug treatments, dose reminders, and training resources. Adherence strategies with an emphasis on oncology are designed to mitigate the possible effects of missed doses, making sure patients execute their targeted therapy, chemotherapy, or immunotherapy regimes.
Region with largest share:
Owing to the region's developing healthcare infrastructure, growing awareness of chronic illnesses, and growing use of digital health solutions, the Asia-Pacific area is anticipated to hold the largest percentage. In order to address the incidence of chronic illnesses, there is an increasing need for medication adherence measures that are effective considering the size and age of the population. Moreover, a recent development in the Asia-Pacific market is the increased creation and use of software-centric solutions that improve patient engagement and adherence by utilizing digital platforms and mobile applications.
Region with highest CAGR:
As a result of growing healthcare investments and government initiatives, the Asia-Pacific area is anticipated to have profitable growth. The Asia Pacific region's varied healthcare landscape and distinct economic circumstances indicate adaptable and culturally sensitive approaches, which is why innovation and customization are essential for tackling the particular opportunities and challenges within the medication adoption market in this vibrant and rapidly changing region.
Key players in the market
Some of the key players in Medication Adherence market include Aardex Group, AdhereTech Inc., Caredose, CareFusion (Becton Dickenson), DrFirst.com, Inc., ELucid MHealth, Fruitech Ltd., Health Beacon, HealthEra, Johnson And Johnson Services Inc, McKesson Corporation, MedAdvisor International Pty Ltd, PHC Holdings Corporation, Propeller Health and Proteus Digital Health.
Key Developments:
In August 2022, Athenahealth added an automated patient engagement feature to help with medication adherence. The new release of the athenaOne EHR and practice management suite includes DrFirst's RxInform automated patient messaging to help patients follow prescribed treatment plans.
In January 2022, CareDxl expanded its medication adherence services with the acquisition of the Transplant Pharmacy. The Transplant Pharmacy provides individualized transplant pharmacy services for patients at multiple transplant centers throughout the United States.
Types Covered:
• Software Centric
• Hardware Centric
• Other Types
Medications Covered:
• Musculoskeletal
• Gastrointestinal
• Oncology
• Diabetes
• Central Nervous System
• Cardiovascular
• Rheumatology
• Other Medications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Medication Adherence Market, By Type
5.1 Introduction
5.2 Software Centric
5.3 Hardware Centric
5.3.1 Automated Dispensing Systems
5.3.2 Electronic Trays
5.3.3 Smart Pill Bottles
5.4 Other Types
6 Global Medication Adherence Market, By Medication
6.1 Introduction
6.2 Musculoskeletal
6.3 Gastrointestinal
6.4 Oncology
6.5 Diabetes
6.6 Central Nervous System
6.7 Cardiovascular
6.8 Rheumatology
6.9 Other Medications
7 Global Medication Adherence Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Aardex Group
9.2 AdhereTech Inc.,
9.3 Caredose
9.4 CareFusion (Becton Dickenson)
9.5 DrFirst.com, Inc.
9.6 ELucid MHealth
9.7 Fruitech Ltd.
9.8 Health Beacon
9.9 HealthEra
9.10 Johnson And Johnson Services Inc
9.11 McKesson Corporation
9.12 MedAdvisor International Pty Ltd
9.13 PHC Holdings Corporation
9.14 Propeller Health
9.15 Proteus Digital Health
List of Tables
1 Global Medication Adherence Market Outlook, By Region (2021-2030) ($MN)
2 Global Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
3 Global Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
4 Global Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
5 Global Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
6 Global Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
7 Global Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
8 Global Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
9 Global Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
10 Global Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
11 Global Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
12 Global Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
13 Global Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
14 Global Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
15 Global Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
16 Global Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
17 Global Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
18 North America Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
19 North America Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
20 North America Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
21 North America Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
22 North America Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
23 North America Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
24 North America Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
25 North America Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
26 North America Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
27 North America Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
28 North America Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
29 North America Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
30 North America Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
31 North America Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
32 North America Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
33 North America Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
34 North America Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
35 Europe Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
36 Europe Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
37 Europe Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
38 Europe Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
39 Europe Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
40 Europe Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
41 Europe Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
42 Europe Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
43 Europe Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
44 Europe Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
45 Europe Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
46 Europe Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
47 Europe Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
48 Europe Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
49 Europe Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
50 Europe Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
51 Europe Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
52 Asia Pacific Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
53 Asia Pacific Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
54 Asia Pacific Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
55 Asia Pacific Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
56 Asia Pacific Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
57 Asia Pacific Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
58 Asia Pacific Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
59 Asia Pacific Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
60 Asia Pacific Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
61 Asia Pacific Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
62 Asia Pacific Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
63 Asia Pacific Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
64 Asia Pacific Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
65 Asia Pacific Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
66 Asia Pacific Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
67 Asia Pacific Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
68 Asia Pacific Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
69 South America Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
70 South America Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
71 South America Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
72 South America Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
73 South America Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
74 South America Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
75 South America Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
76 South America Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
77 South America Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
78 South America Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
79 South America Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
80 South America Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
81 South America Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
82 South America Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
83 South America Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
84 South America Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
85 South America Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
86 Middle East & Africa Medication Adherence Market Outlook, By Country (2021-2030) ($MN)
87 Middle East & Africa Medication Adherence Market Outlook, By Type (2021-2030) ($MN)
88 Middle East & Africa Medication Adherence Market Outlook, By Software Centric (2021-2030) ($MN)
89 Middle East & Africa Medication Adherence Market Outlook, By Hardware Centric (2021-2030) ($MN)
90 Middle East & Africa Medication Adherence Market Outlook, By Automated Dispensing Systems (2021-2030) ($MN)
91 Middle East & Africa Medication Adherence Market Outlook, By Electronic Trays (2021-2030) ($MN)
92 Middle East & Africa Medication Adherence Market Outlook, By Smart Pill Bottles (2021-2030) ($MN)
93 Middle East & Africa Medication Adherence Market Outlook, By Other Types (2021-2030) ($MN)
94 Middle East & Africa Medication Adherence Market Outlook, By Medication (2021-2030) ($MN)
95 Middle East & Africa Medication Adherence Market Outlook, By Musculoskeletal (2021-2030) ($MN)
96 Middle East & Africa Medication Adherence Market Outlook, By Gastrointestinal (2021-2030) ($MN)
97 Middle East & Africa Medication Adherence Market Outlook, By Oncology (2021-2030) ($MN)
98 Middle East & Africa Medication Adherence Market Outlook, By Diabetes (2021-2030) ($MN)
99 Middle East & Africa Medication Adherence Market Outlook, By Central Nervous System (2021-2030) ($MN)
100 Middle East & Africa Medication Adherence Market Outlook, By Cardiovascular (2021-2030) ($MN)
101 Middle East & Africa Medication Adherence Market Outlook, By Rheumatology (2021-2030) ($MN)
102 Middle East & Africa Medication Adherence Market Outlook, By Other Medications (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
